Results 221 to 230 of about 48,901 (273)

Comparison of the GRACE, HEART and TIMI Score to Predict Major Adverse Cardiac Events in Chest Pain Patients at the Emergency Department

open access: yesInternational Journal of Cardiology, 2017
BACKGROUND The performance of the GRACE, HEART and TIMI scores were compared in predicting the probability of major adverse cardiac events (MACE) in chest pain patients presenting at the emergency department (ED), in particular their ability to identify ...
Pieter A Doevendans   +2 more
exaly   +2 more sources

Impact of Preprocedural TIMI Flow on Clinical Outcome in Low-Risk Patients With ST-Elevation Myocardial Infarction: Results From the ATLANTIC Study

Catheterization and Cardiovascular Interventions, 2020
This study sought to analyze the impact of the preprocedural thrombolysis in myocardial infarction (TIMI) flow on clinical outcome in patients with ST‐elevation myocardial infarction (STEMI).
Eric Vicaut, Christian Hamm, Timm Bauer
exaly   +2 more sources

Cancer Risk Associated with Lorcaserin - The FDA's Review of the CAMELLIA-TIMI 61 Trial.

New England Journal of Medicine, 2020
Cancer Risk Associated with Lorcaserin In early 2020, the FDA requested that the manufacturer of lorcaserin voluntarily withdraw the drug from the market because of a signal of increased cancer ris...
J. Sharretts   +5 more
semanticscholar   +1 more source

Efficacy and Safety of Dapagliflozin in the Elderly: Analysis From the DECLARE–TIMI 58 Study

Diabetes Care, 2019
OBJECTIVE Data regarding the effects of sodium–glucose cotransporter 2 inhibitors in the elderly (age ≥65 years) and very elderly (age ≥75 years) are limited. RESEARCH DESIGN AND METHODS The Dapagliflozin Effect on Cardiovascular Events (DECLARE)–TIMI 58
A. Cahn   +16 more
semanticscholar   +1 more source

Clinical outcomes, edoxaban concentration, and anti-factor Xa activity of Asian patients with atrial fibrillation compared with non-Asians in the ENGAGE AF-TIMI 48 trial.

European Heart Journal, 2019
AIMS Prior studies suggested that the risks of ischaemic stroke and bleeding in patients of Asian race with atrial fibrillation (AF) may be higher than that of non-Asians.
T. Chao   +7 more
semanticscholar   +1 more source

The design and rationale for the Dapagliflozin Effect on Cardiovascular Events (DECLARE)–TIMI 58 Trial

American Heart Journal, 2018
Background: Dapagliflozin is a sodium‐glucose co‐transporter‐2 (SGLT‐2) inhibitor that reduces blood glucose in patients with type 2 diabetes mellitus (T2DM) by promoting glycosuria via inhibiting urinary glucose reabsorption.
S. Wiviott   +15 more
semanticscholar   +1 more source

Corrected timi frame count : time to replace the TIMI flow?

European Heart Journal
Abstract Background Thrombolysis In Myocardial Infarction (TIMI) flow grade had been widely accepted method for evaluating coronary artery perfusion following Percutaneous Coronary Intervention (PCI).
I Farissa   +10 more
openaire   +1 more source

Implications of the TIMI Trials

1990
The TIMI Trials consist of three primary studies plus numerous ancillary observations. TIMI I was the direct reperfusion comparison between streptokinase and TPA. The central observations were: Higher reperfusion rates with TPA; Equivalent frequencies of bleeding complications; No differences in clinical outcome parameters; Only early reperfusion ...
openaire   +2 more sources

Insights into the Pathophysiology of Acute Ischemic Syndromes Using the TIMI Flow Grade, TIMI Frame Count, and TIMI Myocardial Perfusion Grade

2003
For over a decade now, the Thrombolysis in Myocardial Infarction (TIMI) flow grade classification scheme has been successfully used to assess coronary blood flow in acute coronary syndromes (1). Although this scheme has been a valuable tool for comparing the efficacy of reperfusion strategies and in identifying patients at higher risk for adverse ...
C. Michael Gibson   +2 more
openaire   +1 more source

Home - About - Disclaimer - Privacy